Yvonne Efebera Selected Research

IPH-2101

11/2012	A phase 1 trial of the anti-KIR antibody IPH2101 in patients with relapsed/refractory multiple myeloma.
12/2011	IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yvonne Efebera Research Topics

Disease

22	Multiple Myeloma 05/2024 - 09/2010
5	Neoplasms (Cancer) 12/2023 - 09/2010
5	Plasma Cell Leukemia 01/2023 - 12/2015
3	Amyloidosis 09/2023 - 01/2020
2	Residual Neoplasm 05/2024 - 11/2020
2	Abdominal Obesity 01/2024 - 09/2023
2	Cardiomyopathies (Cardiomyopathy) 09/2023 - 01/2022
2	Neutropenia 01/2023 - 01/2020
2	Infections 01/2023 - 11/2021
2	Amyloid Plaque 01/2022 - 11/2011
2	Disease Progression 01/2022 - 01/2019
2	Transthyretin-Related Hereditary Amyloidosis 01/2022 - 11/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2021 - 02/2021
2	Bronchiolitis Obliterans Syndrome 01/2016 - 01/2016
2	Paraproteinemias (Monoclonal Gammopathy) 11/2011 - 06/2011
1	Polyneuropathies (Polyneuropathy) 11/2023
1	Herpes Simplex 01/2023
1	cell-associated neurotoxicity 01/2023
1	Cytokine Release Syndrome 01/2023
1	Cytopenia 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Hodgkin Disease (Hodgkin's Disease) 01/2023
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2023
1	Mucositis 01/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Febrile Neutropenia 01/2023
1	Dizziness (Lightheadedness) 01/2022
1	Bradycardia 01/2022
1	Fatigue 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Glomerulonephritis 08/2021
1	Immunoglobulin Light-chain Amyloidosis 11/2020
1	Lymphoma (Lymphomas) 01/2020
1	Heavy Chain Disease 01/2020

Drug/Important Bio-Agent (IBA)

8	Lenalidomide (CC 5013)FDA Link 05/2024 - 12/2011
6	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022 - 06/2011
5	trans-crotonin (CTN)IBA 01/2024 - 01/2019
5	Bortezomib (Velcade)FDA Link 12/2022 - 01/2019
4	Amyloid (Amyloid Fibrils)IBA 09/2023 - 11/2011
3	Melphalan (Alkeran)FDA LinkGeneric 01/2023 - 09/2009
3	daratumumabIBA 12/2022 - 08/2021
3	LigandsIBA 11/2012 - 09/2010
2	Prealbumin (Transthyretin)IBA 09/2023 - 11/2011
2	Monoclonal AntibodiesIBA 01/2023 - 11/2020
2	Immunoglobulins (Immunoglobulin)IBA 08/2021 - 11/2012
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 01/2016
2	IPH-2101IBA 11/2012 - 12/2011
1	VaccinesIBA 12/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2023
1	Myelin-Associated GlycoproteinIBA 11/2023
1	revusiranIBA 09/2023
1	tafamidisIBA 09/2023
1	patisiranIBA 09/2023
1	InotersenIBA 09/2023
1	Diflunisal (Dolobid)FDA Link 09/2023
1	ixazomibIBA 01/2023
1	Brentuximab VedotinIBA 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 01/2023
1	Prostaglandins FIBA 01/2023
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2023
1	Bispecific AntibodiesIBA 01/2023
1	Proteasome InhibitorsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Technetium-99IBA 01/2022
1	Adrenergic beta-Antagonists (beta-Adrenergic Blocking Agents)IBA 01/2022
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2022
1	letermovirIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 11/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 02/2021
1	selinexorIBA 11/2020
1	Chimeric Antigen ReceptorsIBA 11/2020
1	tourmalineIBA 11/2020
1	venetoclaxIBA 11/2020
1	Immunoconjugates (Immunoconjugate)IBA 11/2020
1	melflufenIBA 09/2020
1	AminopeptidasesIBA 09/2020
1	Alkylating AgentsIBA 09/2020
1	Peptide Hydrolases (Proteases)FDA Link 09/2020
1	Peptides (Polypeptides)IBA 09/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Bendamustine Hydrochloride FDA Link 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	Rituximab (Mabthera)FDA Link 01/2020
1	Levofloxacin (Levaquin)FDA Link 01/2020
1	Etoposide (VP 16)FDA LinkGeneric 01/2020
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2020

Therapy/Procedure

15	Therapeutics 03/2024 - 09/2010
12	Cell Transplantation 05/2024 - 12/2015
4	Stem Cell Transplantation 02/2021 - 11/2020
3	Homologous Transplantation 01/2023 - 09/2009
3	Transplantation 02/2021 - 12/2015
2	Hematopoietic Stem Cell Transplantation 01/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2022
1	Induction Chemotherapy 01/2023
1	Genomic Medicine 01/2022
1	Precision Medicine 01/2022
1	Autologous Transplantation 01/2019